Surgery for mesothelioma? The debate continues

The Lancet Oncology

Volumn 12, Issue 8, 2011, Pages 713-714

  Kindler, Hedy Lee ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE; PEMETREXED; PLATINUM COMPLEX;

CANCER ADJUVANT THERAPY; CANCER SURVIVAL; DECORTICATION; HUMAN; LETTER; LUNG RESECTION; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PLEURECTOMY; PRIORITY JOURNAL; PROGNOSIS;

FEMALE; HUMANS; MALE; MESOTHELIOMA; PLEURAL NEOPLASMS; PNEUMONECTOMY;

EID: 79960892034     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70179-6     Document Type: Letter

References (6)

1. Sugarbaker DJ, Wolf AS, Chirieac LR, et al. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Eur J Cardiothorac Surg 2011, published online Feb 8. 10.1016/j.ejcts.2010.12.024.
2. Flores RM, Zakowski M, Venkatraman E, et al. Prognostic faeatures in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol 2007, 2:957-965.
3. Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thoracic Cardiovasc Surg 2008, 135:620-626.
4. Campbell NP, Kindler HL Update on malignant pleural mesothelioma. Semin Respir Crit Care Med 2011, 32:102-110.
5. Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011, published online July 1. 10.1016/S1470-2045(11)70149-8.
6. Gordon GJ, Dong L, Yeap BY, et al. Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma. J Natl Cancer Inst 2009, 101:678-686.